Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
Conditions: Gastrinoma; Glucagonoma; Insulinoma; Metastatic Gastrointestinal Carcinoid Tumor; Pancreatic Polypeptide Tumor; Pulmonary Carcinoid Tumor; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Islet Cell Carcinoma; SomatostatinomaInterventions: Drug: regorafenib; Other: laboratory biomarker analysisSponsors: University of Southern California; National Cancer Institute (NCI)Not yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2014 Category: Research Source Type: clinical trials
RegisterNET - A Registry for Neuroendocrine Tumors in the USA
Conditions: Neuroendocrine Tumor; Carcinoid; Neuroendocrine CarcinomaIntervention: Device: NETestSponsor: Wren Laboratories LLCRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2014 Category: Research Source Type: clinical trials